Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1Electronic supplementary information (ESI) available: General chemistry procedures. Procedures and data for purified compounds. Experimental for biochemical assays and computational docking studies. Analysis of X-ray crystallographic data, NMR data and density functional theory (DFT) calculations for determining the double bond configuration. See DOI: 10.1039/c0ob00025f
Recently, we described the first small-molecule inhibitor, ( E )-ethyl 2-cyano-3-(3,4-dichlorophenyl)acryloylcarbamate ( 1 ), of the PDZ domain of protein interacting with Cα-kinase 1 (PICK1), a potential drug target against brain ischemia, pain and cocaine addiction. Herein, we explore structure-ac...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Recently, we described the first small-molecule inhibitor, (
E
)-ethyl 2-cyano-3-(3,4-dichlorophenyl)acryloylcarbamate (
1
), of the PDZ domain of protein interacting with Cα-kinase 1 (PICK1), a potential drug target against brain ischemia, pain and cocaine addiction. Herein, we explore structure-activity relationships of
1
by introducing subtle modifications of the acryloylcarbamate scaffold and variations of the substituents on this scaffold. The configuration around the double bond of
1
and analogues was settled by a combination of X-ray crystallography, NMR and density functional theory calculations. Thereby, docking studies were used to correlate biological affinities with structural considerations for ligand-protein interactions. The most potent analogue obtained in this study showed an improvement in affinity compared to
1
and is currently a lead in further studies of PICK1 inhibition.
Structure-activity studies of the first small-molecule inhibitor of the PICK1 PDZ domain leading to improved affinity. |
---|---|
ISSN: | 1477-0520 1477-0539 |
DOI: | 10.1039/c0ob00025f |